Cited by 64

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Transcriptome profiling unveils the role of cholesterol in IL-17A signaling in psoriasis

Varshney, Pallavi, Narasimhan, Aarti, Mittal, Shankila, Malik, Garima, Sardana, Kabir, Saini, Neeru·2016·Scientific Reports

Abstract

Psoriasis is a chronic inflammatory skin disease characterized by altered proliferation and differentiation of keratinocytes as well as infiltration of immune cells. Increased expression of Th17 cells and cytokines secreted by them provides evidence for its central role in the pathogenesis of psoriasis. IL-17A, signature cytokine of Th17 cells was found to be highly differentially expressed in psoriatic lesional skin. However, cellular and molecular mechanism by which IL-17A exerts its function on keratinocyte is incompletely understood. To understand IL-17A mediated signal transduction pathways, gene expression profiling was done and differentially expressed genes were analysed by IPA software. Here, we demonstrate that during IL-17A signaling total cholesterol levels were elevated, which in turn resulted in the suppression of genes of cholesterol and fatty acid biosynthesis. We found that accumulation of cholesterol was essential for IL-17A signaling as reduced total cholesterol levels by methyl β cyclodextrin (MBCD), significantly decreased IL-17A induced secretion of CCL20, IL-8 and S100A7 from the keratinocytes. To our knowledge this study for the first time unveils that high level of intracellular cholesterol plays a crucial role in IL-17A signaling in keratinocytes and may explain the strong association between psoriasis and dyslipidemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep19295

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cholesterol homeostasis is disrupted in psoriatic lesions, with upregulation of cholesterol synthesis pathways, elevated free cholesterol, and disrupted cellular cholesterol homeostasis.

    “spatial proteomic and biochemical analyses demonstrate significant upregulation of cholesterol synthesis pathways, elevated free cholesterol levels, and disrupted cellular cholesterol homeostasis14–17.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 35

  1. Perera, G. K., Di Meglio, P. & Nestle, F. O. Psoriasis. Annu. Rev. Pathol. 7, 385–422 (2012). · DOI
  2. Liu, Y., Krueger, J. G. & Bowcock, A. M. Psoriasis: genetic associations and immune system changes. Genes Immun. 8, 1–12 (2007). · DOI
  3. Langan, S. M. et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J. Invest. Dermatol. 132, 556–62 (2012). · DOI
  4. Gelfand, J. M. et al. The risk of stroke in patients with psoriasis. J. Invest. Dermatol. 129, 2411–8 (2009). · DOI
  5. Lowes, M. A. et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J. Invest. Dermatol. 128, 1207–11 (2008). · DOI
  6. Lowes, M. A., Bowcock, A. M. & Krueger, J. G. Pathogenesis and therapy of psoriasis. Nature 445, 866–73 (2007). · DOI
  7. Morishima, N., Mizoguchi, I., Takeda, K., Mizuguchi, J. & Yoshimoto, T. TGF-beta is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23. Biochem. Biophys. Res. Commun. 386, 105–10 (2009). · DOI
  8. Di Cesare, A., Di Meglio, P. & Nestle, F. O. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J. Invest. Dermatol. 129, 1339–50 (2009). · DOI
  9. Nair, R. P. et al. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J. Invest. Dermatol. 128, 1653–61 (2008). · DOI
  10. McKenzie, B. S., Kastelein, R. A. & Cua, D. J. Understanding the IL-23–IL-17 immune pathway. Trends Immunol. 27, 17–23 (2006). · DOI
  11. Nograles, K. E. et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br. J. Dermatol. 159, 1092–102 (2008).
  12. Wolk, K. et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36, 1309–23 (2006). · DOI
  13. Horton, J. D., Goldstein, J. L. & Brown, M. S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125–31 (2002). · DOI · Paper page
  14. Brown, M. S. & Goldstein, J. L. The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor. Cell 89, 331–340 (1997). · DOI · Paper page
  15. Harper, E. G. et al. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J. Invest. Dermatol. 129, 2175–83 (2009). · DOI
  16. Mahammad, S. & Parmryd, I. Cholesterol depletion using methyl-β-cyclodextrin. Methods Mol. Biol. 1232, 91–102 (2015). · DOI
  17. Norman, A. W., Demel, R. A., de Kruyff, B. & van Deenen, L. L. Studies on the biological properties of polyene antibiotics. Evidence for the direct interaction of filipin with cholesterol. J. Biol. Chem. 247, 1918–29 (1972). · DOI
  18. Cua, D. J. & Tato, C. M. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10, 479–89 (2010). · DOI
  19. Shen, F., Hu, Z., Goswami, J. & Gaffen, S. L. Identification of common transcriptional regulatory elements in interleukin-17 target genes. J. Biol. Chem. 281, 24138–48 (2006). · DOI
  20. Tohyama, M. et al. IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression. Eur. J. Immunol. 39, 2779–88 (2009). · DOI
  21. Chiricozzi, A. et al. Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J. Invest. Dermatol. 131, 677–87 (2011). · DOI · Paper page
  22. Erbel, C. et al. IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis. J. Immunol. 193, 4344–55 (2014). · DOI
  23. Salvatore, G. et al. Human monocyte-derived dendritic cells turn into foamy dendritic cells with IL-17A. J. Lipid Res. 56, 1110–22 (2015). · DOI
  24. Tsambaos, D. & Mahrle, G. The phospholipid pattern in the involved and the uninvolved psoriatic epidermis. Arch. Dermatol. Res. 266, 177–80 (1979). · DOI
  25. Wu, S., Li, W.-Q., Han, J., Sun, Q. & Qureshi, A. A. Hypercholesterolemia and Risk of Incident Psoriasis and Psoriatic Arthritis in US Women. Arthritis Rheumatol. 66, 304–310 (2014). · DOI
  26. Jones, S. M. Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease. Ann. Rheum. Dis. 59, 904–909 (2000). · DOI
  27. Mehta, N. N. & Gelfand, J. M. High-density lipoprotein cholesterol function improves after successful treatment of psoriasis: a step forward in the right direction. J. Invest. Dermatol. 134, 592–5 (2014). · DOI
  28. Kölliker Frers, R. A. et al. Psoriasis and cardiovascular risk: Immune-mediated crosstalk between metabolic, vascular and autoimmune inflammation. IJC Metab. Endocr. 6, 43–54 (2015). · DOI
  29. Armstrong, A. W., Voyles, S. V, Armstrong, E. J., Fuller, E. N. & Rutledge, J. C. A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis. Exp. Dermatol. 20, 544–9 (2011). · DOI
  30. Shirinsky, I. V. & Shirinsky, V. S. Efficacy of simvastatin in plaque psoriasis: A pilot study. J. Am. Acad. Dermatol. 57, 529–31 (2007). · DOI
  31. Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001). · DOI · Paper page
  32. Chhabra, R., Dubey, R. & Saini, N. Gene expression profiling indicate role of ER stress in miR-23a~27a~24-2 cluster induced apoptosis in HEK293T cells. RNA Biol. 8, 648–664 (2014). · DOI
  33. Dubey, R., Chhabra, R. & Saini, N. Small interfering RNA against transcription factor STAT6 leads to increased cholesterol synthesis in lung cancer cell lines. PLoS One 6, e28509 (2011). · DOI
  34. Yadav, V., Sultana, S., Yadav, J. & Saini, N. Gatifloxacin induces S and G2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53. PLoS One 7, e47796 (2012). · DOI
  35. Klein, U., Gimpl, G. & Fahrenholz, F. Alteration of the Myometrial Plasma Membrane Cholesterol Content with .beta.-Cyclodextrin Modulates the Binding Affinity of the Oxytocin Receptor. Biochemistry 34, 13784–13793 (1995). · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Varshney, P., Narasimhan, A., Mittal, S., Malik, G., Sardana, K., & Saini, N.
Venue
Scientific Reports
Published
2016-01-19
Volume
6
Issue
1
ISSN
2045-2322
Cited by
64
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review